ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 503,27
-2,66%
Dow Jones
38 589,16
-0,15%
DAX
18 002,02
-1,43%
Brent Oil
82,275
0,00%
Bitcoin
66 636,53
0,67%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. TRACON Pharmaceuticals Inc (TCON)

  7. TRACON Pharmaceuticals Inc (TCON) Actualités

TCON

TRACON Pharmaceuticals (TCON)

TRACON Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:TCON
DateHeureSourceTitreSymboleSociété
12/06/202415h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TCONTRACON Pharmaceuticals Inc
14/05/202423h00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TCONTRACON Pharmaceuticals Inc
13/05/202423h00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TCONTRACON Pharmaceuticals Inc
07/03/202423h03Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TCONTRACON Pharmaceuticals Inc
05/03/202423h00Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:TCONTRACON Pharmaceuticals Inc
28/02/202422h02GlobeNewswire Inc.TRACON to Report Fourth Quarter and Year-End 2023 Financial Results and Provide Corporate Update on March 5, 2024NASDAQ:TCONTRACON Pharmaceuticals Inc
14/02/202422h31Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TCONTRACON Pharmaceuticals Inc
09/02/202422h05Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:TCONTRACON Pharmaceuticals Inc
07/08/202323h02Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:TCONTRACON Pharmaceuticals Inc
25/07/202323h19Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:TCONTRACON Pharmaceuticals Inc
20/06/202314h09Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TCONTRACON Pharmaceuticals Inc
02/06/202322h47Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:TCONTRACON Pharmaceuticals Inc
01/06/202312h06Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:TCONTRACON Pharmaceuticals Inc
31/05/202322h22Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:TCONTRACON Pharmaceuticals Inc
19/05/202323h02Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:TCONTRACON Pharmaceuticals Inc
03/05/202322h02GlobeNewswire Inc.TRACON to Report First Quarter 2023 Financial Results and Provide Corporate Update on May 10, 2023NASDAQ:TCONTRACON Pharmaceuticals Inc
28/04/202312h23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TCONTRACON Pharmaceuticals Inc
06/04/202314h30GlobeNewswire Inc.Runway Growth Finance Corp. Provides First Quarter 2023 Portfolio UpdateNASDAQ:TCONTRACON Pharmaceuticals Inc
16/03/202311h02Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:TCONTRACON Pharmaceuticals Inc
08/03/202323h40Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:TCONTRACON Pharmaceuticals Inc
08/03/202323h19Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:TCONTRACON Pharmaceuticals Inc
08/03/202323h16Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:TCONTRACON Pharmaceuticals Inc
08/03/202322h58Edgar (US Regulatory)Annual Report (10-k)NASDAQ:TCONTRACON Pharmaceuticals Inc
14/02/202318h58Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TCONTRACON Pharmaceuticals Inc
13/02/202323h11Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:TCONTRACON Pharmaceuticals Inc
10/01/202314h30GlobeNewswire Inc.Runway Growth Finance Corp. Provides Fourth Quarter 2022 Portfolio UpdateNASDAQ:TCONTRACON Pharmaceuticals Inc
22/11/202215h35TipRanksTRACON Pharmaceuticals (TCON) Receives a Buy from Maxim GroupNASDAQ:TCONTRACON Pharmaceuticals Inc
21/11/202216h05TipRanksH.C. Wainwright Sticks to Its Buy Rating for TRACON Pharmaceuticals (TCON)NASDAQ:TCONTRACON Pharmaceuticals Inc
16/11/202220h25TipRanksMaxim Group Remains a Buy on TRACON Pharmaceuticals (TCON)NASDAQ:TCONTRACON Pharmaceuticals Inc
15/11/202223h05TipRanksJonesTrading Sticks to Its Buy Rating for TRACON Pharmaceuticals (TCON)NASDAQ:TCONTRACON Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:TCON

Dernières Valeurs Consultées

NYSE
DIS
Walt Disney
EU
AI
Air Liquide
NYSE
JPM
JP Morgan Chase
EU
AF
Air FranceKLM
EU
BN
Danone
NASDAQ
AMZN
Amazon.com
EU
HO
Thales
EU
PX4
SBF 120
COIN
BTCUSD
Bitcoin
EU
BNP
BNP Paribas
NYSE
MCD
McDonalds
FTSE
UKX
FTSE 100
EU
VIV
Vivendi
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés